{"entity":{"type":"insider","cik":"0001374946","url":"/insider/0001374946","json_url":"/insider/0001374946.json","name":"ARGYLL BIOTECHNOLOGIES LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":8,"first":"2007-07-13","last":"2010-04-15","span_basis":"filed_date"},"name_variants":[{"name":"ARGYLL BIOTECHNOLOGIES LLC","source":"filing","n_filings":8,"first_seen":"2007-07-13","last_seen":"2010-04-15"}],"transactions":[{"id":7496954,"accession":"0001437749-10-001097","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-10-001097","line_url":"/filing/0001437749-10-001097#line-4","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"IMYN","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":null,"owner_name":"Miceli James T; ARGYLL BIOTECHNOLOGIES LLC; McClain Douglas A Jr","owner_display_name":"Miceli James T","owner_url":null,"role":"Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":145363798.0,"shares_owned_after_display":"145,363,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-13","filed_date":"2010-04-15","scope":"insider"},{"id":3757791,"accession":"0000950120-08-000101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000101","line_url":"/filing/0000950120-08-000101#line-1","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"IMYN","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":"0001374946","owner_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_display_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_url":"/insider/0001374946","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":145363798.0,"shares_owned_after_display":"145,363,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-13","filed_date":"2008-03-20","scope":"insider"},{"id":8469933,"accession":"0000950120-07-000705","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-07-000705","line_url":"/filing/0000950120-07-000705#line-1","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"IMYN","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":"0001374946","owner_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_display_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_url":"/insider/0001374946","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5333.0,"shares_display":"5,333","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":39997.5,"total_display":"39,997.50","total_whole":"39,998","shares_owned_after":145763798.0,"shares_owned_after_display":"145,763,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-01","filed_date":"2007-11-05","scope":"insider"},{"id":7496951,"accession":"0001437749-10-001097","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-10-001097","line_url":"/filing/0001437749-10-001097#line-3","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"IMYN","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":null,"owner_name":"Miceli James T; ARGYLL BIOTECHNOLOGIES LLC; McClain Douglas A Jr","owner_display_name":"Miceli James T","owner_url":null,"role":"Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5333.0,"shares_display":"5,333","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":39997.5,"total_display":"39,997.50","total_whole":"39,998","shares_owned_after":145763798.0,"shares_owned_after_display":"145,763,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-01","filed_date":"2010-04-15","scope":"insider"},{"id":7606372,"accession":"0000950120-07-000685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950120-07-000685","line_url":"/filing/0000950120-07-000685#line-2","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"IMYN","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":"0001374946","owner_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_display_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_url":"/insider/0001374946","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":145769131.0,"shares_owned_after_display":"145,769,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-24","filed_date":"2007-10-26","scope":"insider"},{"id":7496948,"accession":"0001437749-10-001097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-10-001097","line_url":"/filing/0001437749-10-001097#line-2","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"IMYN","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":null,"owner_name":"Miceli James T; ARGYLL BIOTECHNOLOGIES LLC; McClain Douglas A Jr","owner_display_name":"Miceli James T","owner_url":null,"role":"Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":145779131.0,"shares_owned_after_display":"145,779,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-24","filed_date":"2010-04-15","scope":"insider"},{"id":7222457,"accession":"0000950120-07-000647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950120-07-000647","line_url":"/filing/0000950120-07-000647","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"IMYN","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":"0001374946","owner_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_display_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_url":"/insider/0001374946","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115067.0,"shares_display":"115,067","price_per_share":7.478273527596965,"price_display":"7.48","price_state":"stated","total_value":860502.5,"total_display":"860,502.50","total_whole":"860,503","shares_owned_after":145795131.0,"shares_owned_after_display":"145,795,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-18","filed_date":"2007-10-22","scope":"insider","n_lines":2},{"id":9211938,"accession":"0000950120-07-000617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950120-07-000617","line_url":"/filing/0000950120-07-000617","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"IMYN","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":"0001374946","owner_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_display_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_url":"/insider/0001374946","role":"Director, Officer (CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":659602.0,"shares_display":"659,602","price_per_share":2.6131515671571646,"price_display":"2.61","price_state":"stated","total_value":1723640.0,"total_display":"1,723,640.00","total_whole":"1,723,640","shares_owned_after":146169800.0,"shares_owned_after_display":"146,169,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-03","filed_date":"2007-10-16","scope":"insider","n_lines":4},{"id":9211855,"accession":"0000950120-07-000471","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950120-07-000471","line_url":"/filing/0000950120-07-000471","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":"0001374946","owner_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_display_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_url":"/insider/0001374946","role":"Director, Officer (CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":113000.0,"shares_display":"113,000","price_per_share":326991.1504424779,"price_display":"326,991.15","price_state":"stated","total_value":36950000000.0,"total_display":"36,950,000,000.00","total_whole":"36,950,000,000","shares_owned_after":146573800.0,"shares_owned_after_display":"146,573,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-23","filed_date":"2007-09-04","scope":"insider","n_lines":2},{"id":9211856,"accession":"0000950120-07-000471","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950120-07-000471","line_url":"/filing/0000950120-07-000471","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":"0001374946","owner_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_display_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_url":"/insider/0001374946","role":"Director, Officer (CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131100.0,"shares_display":"131,100","price_per_share":616720.4424103737,"price_display":"616,720.44","price_state":"stated","total_value":80852050000.0,"total_display":"80,852,050,000.00","total_whole":"80,852,050,000","shares_owned_after":146569800.0,"shares_owned_after_display":"146,569,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-20","filed_date":"2007-09-04","scope":"insider","n_lines":2},{"id":9211853,"accession":"0000950120-07-000471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-07-000471","line_url":"/filing/0000950120-07-000471","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":"0001374946","owner_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_display_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_url":"/insider/0001374946","role":"Director, Officer (CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":412100.0,"shares_display":"412,100","price_per_share":556128.3669012375,"price_display":"556,128.37","price_state":"stated","total_value":229180500000.0,"total_display":"229,180,500,000.00","total_whole":"229,180,500,000","shares_owned_after":146923000.0,"shares_owned_after_display":"146,923,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-26","filed_date":"2007-09-04","scope":"insider","n_lines":4},{"id":9211848,"accession":"0000950120-07-000410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-07-000410","line_url":"/filing/0000950120-07-000410#line-1","is_derivative":false,"issuer_cik":"0001374946","issuer_name":"IMMUNOSYN CORP","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001374946","owner_cik":"0001374946","owner_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_display_name":"ARGYLL BIOTECHNOLOGIES LLC","owner_url":"/insider/0001374946","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":412100.0,"shares_display":"412,100","price_per_share":2060500.0,"price_display":"2,060,500.00","price_state":"stated","total_value":849132050000.0,"total_display":"849,132,050,000.00","total_whole":"849,132,050,000","shares_owned_after":146587900.0,"shares_owned_after_display":"146,587,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-26","filed_date":"2007-07-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001375623","name":"IMMUNOSYN CORP","url":"/issuer/0001375623","role":"Director, Officer (CFO, Secretary), Ten percent owner","n_filings":8,"first_seen":"2007-07-13","last_seen":"2010-04-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001374946","retrieved_at":"2026-08-25T05:43:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}